Sie suchten nach: Cholesterol-3-sulphate+sodium+salt
223 results were found
Final fill for mAbs
/cms/it/bioprocessing_mabs_final_fill
Final fill for mAbs Progressing from the drug substance to the final injectable drug product requires final packaging vials and stoppers that meet a number of quality requirements. To meet these requirements products must be prepared in an ISO Cla...
ls ge29064295 20131220222354
/m-ch.vwr.com/fr_CH/images/ls_ge29064295_20131220222354.pdf
imagination at work Application note 29-0642-95 AA Chromatography systems Depletion of albumin from serum samples using ÄKTA™ start Albumin comprises 55% to 65% of the total protein in serum. The abundance of this protein makes it difficult to stu...
Final fill for cell therapy
/cms/fr/bioprocessing_cell_therapy_final_fill
Final fill for cell therapy The cell therapy drug product is configured in different ways depending on the required delivery of the cells/tissues. For example delivery of chondrocytes for cartilage repair is administered by an injection. Expanded ...
Upstream processing for cell therapy
/cms/de/bioprocessing_cell_therapy_upstream_processing
Upstream processing for cell therapy Compared to production volumes associated with other biologics (e.g. mAbs: 2000L to 10000L) cell therapy production volumes are more commonly between 1L to 10L. Even the quality parameters are different. Instea...
Final fill for vaccines
/cms/de/bioprocessing_vaccines_final_fill
Final fill for vaccines Progressing from the drug substance to the final injectable drug product requires final packaging vials and stoppers that meet a number of quality requirements. To meet these requirements products must be prepared in an ISO...
Montreal Manufacturing Facility
/cms/fr/montreal_manufacturing_facility
Montreal Manufacturing Facility The off-loading manifold at our Montreal QC manufacturing facility which includes 8600 sq. ft. for manufacturing 2200 sq. ft. for quality control and a 22800 sq. ft. warehouse. Core Capabilities Production of labora...
Montreal Manufacturing Facility
/cms/it/montreal_manufacturing_facility
Montreal Manufacturing Facility The off-loading manifold at our Montreal QC manufacturing facility which includes 8600 sq. ft. for manufacturing 2200 sq. ft. for quality control and a 22800 sq. ft. warehouse. Core Capabilities Production of labora...
Final fill for vaccines
/cms/fr/bioprocessing_vaccines_final_fill
Final fill for vaccines Progressing from the drug substance to the final injectable drug product requires final packaging vials and stoppers that meet a number of quality requirements. To meet these requirements products must be prepared in an ISO...
Masterflex Connection Newsletter Vol.3-3 - Specialty pump tubing is the winner in those challenging applications
/cms/de/tech-article-masterflex-connection-newsletter-vol-3-3-specialty-pump-tubing
Masterflex Connection Newsletter Vol.3-3 - Specialty pump tubing is the winner in those challenging applications Specialty pump tubing is the winner in those challenging applications Masterflex® tubing pumps are ideal for pumping chemicals. The pe...
Final fill for vaccines
/cms/it/bioprocessing_vaccines_final_fill
Final fill for vaccines Progressing from the drug substance to the final injectable drug product requires final packaging vials and stoppers that meet a number of quality requirements. To meet these requirements products must be prepared in an ISO...
Masterflex Connection Newsletter Vol.3-3 - Specialty pump tubing is the winner in those challenging applications
/cms/it/tech-article-masterflex-connection-newsletter-vol-3-3-specialty-pump-tubing
Masterflex Connection Newsletter Vol.3-3 - Specialty pump tubing is the winner in those challenging applications Specialty pump tubing is the winner in those challenging applications Masterflex® tubing pumps are ideal for pumping chemicals. The pe...
Downstream purification for recombinant proteins
/cms/fr/bioprocessing_recombinant_proteins_downstream_purification
Downstream purification for recombinant proteins With more than 30 years of chromatography experience developed products and services we have every solution to meet your needs. Our J.T.Baker® brand BAKERBOND™ chromatography resins have been used s...
Final fill for cell therapy
/cms/de/bioprocessing_cell_therapy_final_fill
Final fill for cell therapy The cell therapy drug product is configured in different ways depending on the required delivery of the cells/tissues. For example delivery of chondrocytes for cartilage repair is administered by an injection. Expanded ...
Upstream processing for mAbs
/cms/de/bioprocessing_mabs_upstream_processing
Upstream processing for mAbs Developing and manufacturing mAbs has moved away from a dependency on raw materials of animal origin. Our biochemical components and supplements are animal component-free to meet the needs of these applications. Produc...
Final fill for mAbs
/cms/fr/bioprocessing_mabs_final_fill
Final fill for mAbs Progressing from the drug substance to the final injectable drug product requires final packaging vials and stoppers that meet a number of quality requirements. To meet these requirements products must be prepared in an ISO Cla...
Downstream purification for recombinant proteins
/cms/it/bioprocessing_recombinant_proteins_downstream_purification
Downstream purification for recombinant proteins With more than 30 years of chromatography experience developed products and services we have every solution to meet your needs. Our J.T.Baker® brand BAKERBOND™ chromatography resins have been used s...
97 - 112 of 223